Navigation Links
Neogen Launches Fully Quantitative Lateral Flow Test for Aflatoxin

LANSING, Mich., Sept. 22, 2011 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) has developed a quick and easy new test for aflatoxin, a toxin considered by many to be the most potent, naturally-occurring carcinogen. The toxin is a by-product of mold growth in a wide range of commodities, including corn. Because it is a known severe threat to human and animal health, more than 100 countries have established regulatory limits for aflatoxin in commodities intended as human food or animal feed.

Neogen's new Reveal® Q+ for Aflatoxin combines the speed and simplicity of a lateral flow screening test, like a home pregnancy test, with the fully quantitative precision of a more demanding testing method. The new test delivers precise results ranging from 2 to 150 parts per billion (ppb) of aflatoxin after only 6 minutes.

"Reveal Q+ for Aflatoxin is the easiest test available for rapid, fully quantitative test results, and uses a more environmentally friendly ethanol extraction," said Ed Bradley, Neogen's vice president for Food Safety. "This innovative technology yields more accurate and reproducible results. Coupled with Neogen's AccuScan III reader, the Reveal Q+ system objectively reads, analyzes and stores test results.

"Reveal Q+ for Aflatoxin is the first in our new line of fully quantitative lateral flow tests for mycotoxins," Bradley continued. "Tests for DON and zearalenone are in the final stages of development. The new Reveal Q+ products add to Neogen's unmatched range of simple and accurate lateral flow, microwell, immunoaffinity column mycotoxin testing options — all of which are backed by the best technical and R&D support in the industry."

Reveal Q+ for Aflatoxin offers both room temperature incubation of the test strip and storage of the test kit — eliminating the need for an incubator and refrigeration space. The test requires only minimal equipment to achieve precise results and a simple low cost ethanol extraction process. Ethanol is the preferred extract solvent of some major grain handlers.

Neogen's AccuScan® III reader provides an easy method to objectively read, store, and analyze results from Neogen's line of lateral flow tests. AccuScan provides a permanent result that can be incorporated into a company's food safety plan, such as HACCP.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Webcast Alert: Neogen Corporation to Announce 1st Quarter Results
2. Neogen Reports 26% Increase in Revenues
3. Neogen Honored by Forbes; Two Brokerage Firms Initiate Coverage
4. NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
5. Neogen Announces New Share Repurchase Program
6. Neogen Reports Best Quarter in Its 26-Year History
7. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
8. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
9. Neogen Names New Senior Science Officer; Added to S&P Index
10. NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
11. NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
Post Your Comments:
(Date:11/24/2015)... PHILADELPIA, PA (PRWEB) , ... November 24, 2015 , ... ... young entrepreneurs at competitive events in five states to develop and pitch their BIG ... student projects from each state are competing for votes to win the title of ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... today that the remaining 11,000 post-share consolidation (or ... Warrants (the "Series B Warrants") subject to the ... on November 23, 2015, which will result in ... giving effect to the issuance of such shares, ...
(Date:11/24/2015)... Telbec/ - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ... Laurin , President and Chief Executive Officer of ProMetic, will ... 27 th Annual Healthcare Conference to be held at ... st , at 8.50am (ET) and ProMetic,s management ... The presentation will be available live via a webcast accessible ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Whitehouse Laboratories ... Laboratory. The new stand-alone facility will be strictly dedicated to basic USP 61, ... and existing clients the chance to have complete chemistry and micro testing performed by ...
Breaking Biology Technology:
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/12/2015)... Nov. 11, 2015   Growing need for ... tools has been paving the way for use ... of discrete analytes in clinical, agricultural, environmental, food ... predominantly used in medical applications, however, their adoption ... due to continuous emphasis on improving product quality ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):